These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 6752473)

  • 1. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
    Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
    Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
    [No Abstract]   [Full Text] [Related]  

  • 3. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure.
    Kato M; Kinugawa T; Omodani H; Osaki S; Ahmmed GU; Ogino K; Hisatome I; Miyakoda H; Thames MD
    J Card Fail; 1996 Jun; 2(2):103-10. PubMed ID: 8798111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.
    Curtiss C; Cohn JN; Vrobel T; Franciosa JA
    Circulation; 1978 Nov; 58(5):763-70. PubMed ID: 699245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
    Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
    Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
    Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of neurohormonal changes following the production of the benign and malignant phases of two-kidney, two-clip Goldblatt hypertension.
    Suzuki H; Saruta T; Ferrario CM; Brosnihan KB
    Jpn Heart J; 1987 May; 28(3):413-26. PubMed ID: 2887673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure.
    Imaizumi T; Takeshita A; Nakamura N; Sakai K; Hirooka Y; Suzuki S; Yoshida M; Nakamura M
    Jpn Heart J; 1990 Nov; 31(6):817-28. PubMed ID: 2084278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of alterations of the renin-angiotensin system and the sympathetic nervous system on plasma bradykinin concentration in patients with essential hypertension].
    Takeda Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1112-24. PubMed ID: 6097486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
    Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
    J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin.
    Holmer SR; Riegger AJ; Notheis WF; Kromer EP; Kochsiek K
    Basic Res Cardiol; 1987; 82(2):101-8. PubMed ID: 2955780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.